Unique ID issued by UMIN | UMIN000053373 |
---|---|
Receipt number | R000060795 |
Scientific Title | Efficacy and Psychological Impact of Advanced Hybrid Closed-Loop for Type 1 Diabetes in Japanese |
Date of disclosure of the study information | 2024/02/01 |
Last modified on | 2024/01/31 14:51:34 |
Efficacy and Psychological Impact of Advanced Hybrid Closed-Loop for Type 1 Diabetes in Japanese
Efficacy of AHCL for Type 1 Diabetes in Japanese
Efficacy and Psychological Impact of Advanced Hybrid Closed-Loop for Type 1 Diabetes in Japanese
Efficacy of AHCL for Type 1 Diabetes in Japanese
Japan |
Type 1 diabetes
Endocrinology and Metabolism |
Others
NO
We will determine the efficacy of the Advanced Hybrid Closed-Loop on glycemic control in Japanese people with type 1 diabetes.
We will also study the psychological impact after the change.
Efficacy
Change from baseline to end of follow-up (at 26 weeks) in the percentage of time that the sensor glucose level was from 70 to 180 mg/dL.
(1) Baseline and end of follow up data for the following items
Percentage of time with sensor glucose levels greater than 181 mg/dL and greater than 251 mg/dL
Percentage of time with sensor glucose levels less than 70 mg/dL and less than 54 mg/dL
Mean, coefficient of variation, and glucose control indicator values for sensor glucose values
Glycemia risk index
Average daily insulin dose, average daily bolus insulin dose, and average daily basal insulin dose
HbA1c
Questionnaire scores (DTSQs, DTSQc, PAID, CSII-QOL, HFS)
(2) CGM logging time and AHCL operating time, number of AHCL suspensions
(3) Average number of blood glucose measurements per day
Observational
18 | years-old | <= |
Not applicable |
Male and Female
(1)18 years of age or older
(2)Patients diagnosed with type 1 diabetes
(3)Patients receiving SAP therapy for more than 3 months
(4)Patients starting to use AHCL
(5)Patients with written informed consent
(1) Patients with cancer
(2) Patients receiving systemic steroids
(3) Pregnant or lactating women
(4) Patients deemed unsuitable as subjects by the principal investigator or research assistant
55
1st name | Satoshi |
Middle name | |
Last name | Kubota |
Shinshu University Hospital
Diabetes, Endocrinology and Metabolism
390-8621
3-1-1 Asahi, Matsumoto City, Nagano Prefecture, Japan
+81263354600
skubota@shinshu-u.ac.jp
1st name | Satoshi |
Middle name | |
Last name | Kubota |
Shinshu University Hospital
Diabetes, Endocrinology and Metabolism
390-8621
3-1-1 Asahi, Matsumoto City, Nagano Prefecture, Japan
+81263354600
skubota@shinshu-u.ac.jp
Shinshu University Hospital
None
Self funding
Shinshu University School of Medicine Life Science and Medical Sciences Research Ethics Committee
3-1-1 Asahi, Matsumoto City, Nagano Prefecture, Japan
+81263372572
mdrinri@shinshu-u.ac.jp
NO
長野赤十字病院(長野県)、長野県厚生農業協同組合連合会南長野医療センター篠ノ井総合病院(長野県)、佐久市立国保浅間総合病院(長野県)、松本協立病院(長野県)、長野県厚生農業協同組合連合会佐久総合病院佐久医療センター(長野県)
2024 | Year | 02 | Month | 01 | Day |
Unpublished
Enrolling by invitation
2024 | Year | 01 | Month | 16 | Day |
2024 | Year | 01 | Month | 16 | Day |
2024 | Year | 01 | Month | 17 | Day |
2026 | Year | 12 | Month | 31 | Day |
This is a multicenter, single-arm, prospective observational study.
During the observation period, patients will be treated as usual.
2024 | Year | 01 | Month | 16 | Day |
2024 | Year | 01 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060795
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |